🎉 M&A multiples are live!
Check it out!

Lumito Valuation Multiples

Discover revenue and EBITDA valuation multiples for Lumito and similar public comparables like Healius, Cyclopharm, and CurveBeam AI.

Lumito Overview

About Lumito

Lumito AB is a Swedish company that specializes in the medical research and development of imaging technology for use in digital pathology. It has developed a development and business plan for the development of an instrument for digital pathology that improves the quality of tissue sample mapping.


Founded

2010

HQ

Sweden
Employees

1

Website

lumito.se

Financials

Last FY Revenue $10K

Last FY EBITDA -$2.7M

EV

$12.4M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 12K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Lumito Financials

In the most recent fiscal year, Lumito achieved revenue of $10K and an EBITDA of -$2.7M.

Lumito expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Lumito valuation multiples based on analyst estimates

Lumito P&L

NTM Last FY FY 2025 FY 2026 FY 2027
Revenue XXX $10K XXX XXX XXX
Gross Profit XXX $0.4M XXX XXX XXX
Gross Margin XXX 4192% XXX XXX XXX
EBITDA XXX -$2.7M XXX XXX XXX
EBITDA Margin XXX -26127% XXX XXX XXX
EBIT XXX -$4.0M XXX XXX XXX
EBIT Margin XXX -38885% XXX XXX XXX
Net Profit XXX -$4.3M XXX XXX XXX
Net Margin XXX -42194% XXX XXX XXX
Net Debt XXX n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

Lumito Stock Performance

As of July 18, 2025, Lumito's stock price is SEK 0 (or $0).

Lumito has current market cap of SEK 125M (or $13.0M), and EV of SEK 119M (or $12.4M).

See Lumito trading valuation data

Lumito Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$12.4M $13.0M XXX XXX XXX XXX n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Lumito Valuation Multiples

As of July 18, 2025, Lumito has market cap of $13.0M and EV of $12.4M.

Lumito's trades at 1203.3x EV/Revenue multiple, and -4.6x EV/EBITDA.

Equity research analysts estimate Lumito's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

Lumito's P/E ratio is not available.

See valuation multiples for Lumito and 12K+ public comps

Lumito Financial Valuation Multiples

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Market cap (current) $13.0M XXX $13.0M XXX XXX XXX
EV (current) $12.4M XXX $12.4M XXX XXX XXX
EV/Revenue n/a XXX 1203.3x XXX XXX XXX
EV/EBITDA n/a XXX -4.6x XXX XXX XXX
EV/EBIT n/a XXX -3.1x XXX XXX XXX
EV/Gross Profit n/a XXX n/a XXX XXX XXX
P/E n/a XXX -3.0x XXX XXX XXX
EV/FCF n/a XXX -3.4x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Lumito Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Lumito Margins & Growth Rates

Lumito's revenue per employee in the last FY averaged $10K, while opex per employee averaged $4.4M for the same period.

Lumito's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Lumito's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Lumito and other 12K+ public comps

Lumito Operational Valuation Multiples

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue Growth n/a XXX n/a XXX XXX XXX
EBITDA Margin n/a XXX -26127% XXX XXX XXX
EBITDA Growth n/a XXX n/a XXX XXX XXX
Rule of 40 n/a XXX n/a XXX XXX XXX
Bessemer Rule of X XXX XXX n/a XXX XXX XXX
Revenue per Employee XXX XXX $10K XXX XXX XXX
Opex per Employee XXX XXX $4.4M XXX XXX XXX
S&M Expenses to Revenue XXX XXX n/a XXX XXX XXX
G&A Expenses to Revenue XXX XXX n/a XXX XXX XXX
R&D Expenses to Revenue XXX XXX n/a XXX XXX XXX
Opex to Revenue XXX XXX 43077% XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Lumito Public Comps

See public comps and valuation multiples for Medical Imaging & Diagnostics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Australian Clinical Labs XXX XXX XXX XXX XXX XXX
Clarity Pharmaceuticals XXX XXX XXX XXX XXX XXX
CurveBeam AI XXX XXX XXX XXX XXX XXX
Cyclopharm XXX XXX XXX XXX XXX XXX
Healius XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Lumito M&A and Investment Activity

Lumito acquired  XXX companies to date.

Last acquisition by Lumito was  XXXXXXXX, XXXXX XXXXX XXXXXX . Lumito acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Lumito

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Start Free Trial

About Lumito

When was Lumito founded? Lumito was founded in 2010.
Where is Lumito headquartered? Lumito is headquartered in Sweden.
How many employees does Lumito have? As of today, Lumito has 1 employees.
Is Lumito publicy listed? Yes, Lumito is a public company listed on NGM.
What is the stock symbol of Lumito? Lumito trades under LUMITO ticker.
When did Lumito go public? Lumito went public in 2018.
Who are competitors of Lumito? Similar companies to Lumito include e.g. Australian Clinical Labs, Clarity Pharmaceuticals, CurveBeam AI, Cyclopharm.
What is the current market cap of Lumito? Lumito's current market cap is $13.0M
Is Lumito profitable? Yes, Lumito is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.